Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493811-15-000002
Filing Date
2015-04-14
Accepted
2015-04-14 16:22:00
Documents
1
Period of Report
2015-04-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 9650
  Complete submission text file 0001493811-15-000002.txt   11069
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Issuer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O FATE THERAPEUTICS, INC. 3535 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
Wolchko J Scott (Reporting) CIK: 0001586893 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36076 | Film No.: 15769448